PNPLA3 and Hepatic fibrosis: However, two recent studies in patients with chronic hepatitis C from Pakistan and Brazil did not find any significant role of PNPLA3 variants in modulating the development of hepatic fibrosis or cirrhosis in these patients [144,145].